Wegovy Singapore – Obesity is a rising healthcare challenge worldwide. Effective weight management therapies are becoming increasingly important as obesity is linked with serious comorbidities such as type 2 diabetes, cardiovascular disease, and hypertension. In Singapore, Wegovy is one of the most recently available medications for chronic weight management. This article provides healthcare professionals in Singapore with an overview of Wegovy, including its mechanism of action, clinical indications, contraindications, administration guidelines, and side effect profiles.
What Is Wegovy?
Wegovy is the brand name for semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist. It was developed to mimic the effects of the natural hormone GLP-1, which regulates appetite and food intake. By delaying gastric emptying and enhancing satiety, Wegovy helps reduce caloric consumption and promote sustainable weight loss.
In Singapore, Wegovy may be of particular interest for healthcare professionals as patient demand for novel pharmacological weight loss solutions rises.
Wegovy Indications
Wegovy is indicated as an adjunct to a reduced-calorie diet and increased physical activity for:
- Adults with a body mass index (BMI) of ≥30 kg/m² (obesity).
- Adults with a BMI of ≥27 kg/m² (overweight) who also have weight-related comorbidities such as hypertension, dyslipidaemia, or type 2 diabetes.
It is not a first-line treatment but rather part of a comprehensive weight management plan.
Contraindications
Healthcare professionals should be aware of the following contraindications:
- Personal or family history of medullary thyroid carcinoma.
- Patients with multiple endocrine neoplasia syndrome type 2 (MEN 2).
- Known hypersensitivity to semaglutide or any excipients in the formulation.
- Pregnancy and breastfeeding, as safety data are limited.
Caution should also be exercised in patients with a history of pancreatitis or severe gastrointestinal disorders.
Administration Instructions
Wegovy is administered as a once-weekly subcutaneous injection. It is typically injected into the abdomen, thigh, or upper arm, with rotation of injection sites recommended.
A stepwise dose escalation is used to minimise gastrointestinal side effects:
- Starting dose of 0.25 mg once weekly.
- Gradual increase over several weeks to a maintenance dose of 2.4 mg once weekly.
Adherence to this titration schedule is crucial to improve patient tolerance.
Stated Side Effects Of Wegovy
The most commonly reported Wegovy side effects include:
- Nausea
- Vomiting
- Diarrhoea
- Constipation
- Abdominal pain
Other possible adverse effects include headache, fatigue, and injection-site reactions.
Reported And Anecdotal Side Effects (Disclaimer)
Beyond clinical trial data, there have been anecdotal or unverified reports from patients using Wegovy. These include:
- Changes in mood or anxiety symptoms.
- Altered taste perception.
- Hair thinning or increased hair loss.
It is essential to emphasise that these reported effects are not formally established in clinical studies. Healthcare professionals should interpret them with caution and advise patients accordingly. Continuous monitoring and reporting of adverse events through official pharmacovigilance channels remain vital.
Frequently Asked Questions
1. Is Wegovy Available In Singapore?
Yes, Wegovy is approved for medical use, but availability may depend on supply and regulatory updates. Healthcare professionals should check with local health authorities for the latest status.
2. How Effective Is Wegovy Compared To Other Weight Loss Drugs?
Clinical trials have shown significant weight reduction, with some patients achieving 15% or more of baseline body weight loss when combined with lifestyle modifications.
3. Can Patients With Type 2 Diabetes Use Wegovy?
Yes, Wegovy is often prescribed to overweight or obese patients with type 2 diabetes, but blood glucose levels must be monitored closely.
4. What Should Patients Do If They Miss A Dose?
If the missed dose is within five days, it can be taken as soon as possible. If more than five days have passed, the next scheduled dose should be administered without doubling.
5. Is Long-Term Use Of Wegovy Safe?
Long-term safety data are still being collected. However, current evidence suggests it can be used for sustained weight management under medical supervision.
Conclusion
With Wegovy, Sugapore healthcare professionals have a valuable tool for the management of obesity and related comorbidities. Its role should always be integrated within a holistic care plan that includes diet, exercise, and behavioural therapy.
Contact Us
For healthcare professionals – for business opportunities:
- MCNAsia – Preferred Doctor, SEO, Website Development, Influencer Marketing, and RED (Xiaohongshu) Marketing
For non-healthcare professionals seeking an appointment with a doctor for weight loss treatment, contact us for assistance via the button below
Contact UsBack To: Obesity In Singapore Main Page
All content on this site is informative only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment, and should never be relied upon for specific medical advice. If you are experiencing a medical emergency, call 995 immediately or go to the nearest Accident & Emergency department.
health365.sg is a member of Group 365Asia.